BCR/ABL Fusion Probe

BCR/ABL Fusion Probe

Product Description:chronic myeloid leukemia(CML)
Applications: Lymphatic hematopoietic system tumor

Send InquiryChat Now
Product Details


BCR/ABL gene fusion probe



◆Product Advantages

1.Fleetness: Tissue probe hybridization time: 2 hours. Cell probe hybridization time: 1 hour.

2.Accuracy: Less non-specific background staining (dyeing). Increase difficult samples detection rate.

3.Reproducibility: Different laboratories test results are highly reproducible.

◆Probe Description


The ABL probe was labeled with orange red dye and the green dye was used to mark the BCR probe. In situ hybridization technique could be used to combine the two probes into the target detection site.

◆Clinical Significance

BCR/ABL fusion gene is a common cytogenetic anomaly in patients with chronic myelocytic leukemia (CML). The BCR/ABL fusion gene can be found in 90% of the CML patients. The prognosis of patients with BCR/ABL fusion gene is poor. It is clinically possible to use the BCR/ABL fusion gene to selectively use the molecular targeted therapeutic drugs . In addition, clinicians can combine other signs of patients to identify patients more effectively.

◆Size Specifications


Hot Tags: BCR/ABL fusion probe, suppliers, manufacturers, customized, discount, IVD, free sample, for laboratories, for hospitals, for research center, rapid diagnosis
Related Products